• Product Sales up a robust 14% over prior year, and a signifi

    المصدر: Buzz FX / 09 مايو 2024 16:26:29   America/New_York


    Product Sales up a robust 14% over prior year, and a significant 22% sequentially
    We believe the STAR-T data presented at AATS support a favorable benefit-to-risk profile of DrugSorb-ATR in coronary artery bypass graft (CABG) patients On tr
    Read more...
شارك على،